BIODESIX, INC. (BDSX) Total liabilities 2019–2025
BIODESIX, INC. (BDSX) total liabilities at each fiscal year-end, per SEC filings.
$89.9MFY2025 · since FY2019: $76.2M → $89.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $89.9M | +17.8% |
| FY2024 | $76.4M | -19.2% |
| FY2023 | $94.5M | +30.7% |
| FY2022 | $72.3M | +28.3% |
| FY2021 | $56.4M | -29.5% |
| FY2020 | $79.9M | +4.8% |
| FY2019 | $76.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BDSX financial trends
BDSX RevenueBDSX Net incomeBDSX Net marginBDSX Gross profitBDSX Gross marginBDSX Operating incomeBDSX Operating marginBDSX Operating cash flowBDSX Free cash flowBDSX Capital expendituresBDSX Return on equityBDSX Stock buybacksBDSX Dividends paidBDSX Total assetsBDSX Shareholders’ equityBDSX overview →